| 5-R01-EB029455-04 |
Immunoengineered nanotechnology for targeted expansion of regulatory T cells |
Jamie Spangler |
Johns Hopkins University |
| 5-R01-EB034086-02 |
Ionic Liquid-Coated NIR-II Polymer Conjugates as Targeted Brain Theranostics |
Davita Watkins |
Ohio State University |
| 1-R01-EB035485-01 |
Nanostructured degradable bone cement for delivering novel antibiotics |
Shiladitya Sengupta |
Brigham And Women'S Hospital |
| 1-R15-EB031388-01 |
Nucleic Acid Nanoparticle-based Monoclonal Antibody Mimics |
Emil Khisamutdinov |
Ball State University |
| 1-R21-EB034942-01 |
Optimization of Tannic Acid Lipid Nanoparticles for a Therapeutic mRNA Vaccine Against Melanoma |
Owen Fenton |
Univ of North Carolina Chapel Hill |
| 5-R21-EB027812-03 |
Painting Vasculature with Photosensitive Liposomes |
Janeta Zoldan |
University of Texas at Austin |
| 5-R21-EB033183-02 |
Photoelectroporation: Biomacromolecule delivery via nanoscale light-amplified voltage generators |
Julie Champion |
Georgia Institute of Technology |
| 5-R03-EB033576-02 |
Physiologically Based Pharmacokinetic Modeling of Silica Nanoparticles |
Venkata Yellepeddi |
University of Utah |
| 5-R01-EB028078-04 |
Plasmonic nanoparticle-mediated immunotherapy to treat metastatic cancer |
Tuan Vo-Dinh |
Duke University |
| 5-R21-EB032991-02 |
Rational Design of Oral Drugs Targeting Mucosa Delivery |
Qun Wang |
Iowa State University |
